Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity-Reference-Cited by-同舟云学术

Predictive factors of metamorphopsia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy with good baseline visual acuity

Published:2020-10-12 Issue:10 Volume:15 Page:e0240557
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hayashida Mayuka,Miki Akiko^ORCID,Nakai Shunichiro,Matsumiya Wataru,Imai Hisanori,Kusuhara Sentaro,Nakamura Makoto

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference14 articles.

1. Central serous chorioretinopathy: an update on pathogenesis and treatment;M Gemenetzi;Eye (Lond),2010

2. Central Serous Chorioretinopathy

3. Half-fluence photodynamic therapy for chronic central serous chorioretinopathy: predisposing factors for visual acuity outcomes;V Mmatuskova;Semin Ophthalmol,2018

4. Half-dose verteporfin PDT for central serous–chorioretinopathy;JM Stewart;Br J Ophthalmol,2006

5. Half-time photodynamic therapy for central serous chorioretinopathy;MJ Tsai;Optom Vis Sci,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laser Treatment of Central Serous Chorioretinopathy – An Update;Klinische Monatsblätter für Augenheilkunde;2024-07-24

2. Aniseikonia after reduced-fluence photodynamic therapy in patients with central serous chorioretinopathy;Scientific Reports;2023-10-10

3. PREVALENCE AND MORPHOLOGIC BIOMARKERS OF METAMORPHOPSIA IN EYES WITH “RESOLVED” CHRONIC CENTRAL SEROUS CHORIORETINOPATHY;Retina;2023-09

4. Two-year outcome of half-time photodynamic therapy for chronic central serous chorioretinopathy with and without choroidal neovascularization;PLOS ONE;2023-05-02

5. Metamorphopsia and Morphological Changes in the Macula after Scleral Buckling Surgery for Macula-Off Rhegmatogenous Retinal Detachment;Journal of Ophthalmology;2021-06-25